Q32 BIO
Q32 Bio is a biotechnology company developing treatments for patients with severe autoimmune and inflammatory diseases. Q32 Bio is addressing dysregulation to help patients take back control of their lives in diseases with few to no treatment options, or those diseases where current therapeutics provide inadequate relief. Q32 Bio consists of a team of scientists and industry veterans with strong expertise in immunology. The team has a strong track record of discovering and developing new and innovative therapies.
Q32 BIO
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.q32bio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
106 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Abalone Bio
Abalone Bio is an early stage biotech start-up that develops antibody drugs for the treatment of diseases.
Akarna Therapeutics
At Akarna, our mission is to develop best-in-class treatments for NASH and other chronic liver diseases
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Cerulean Pharma
Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
DermBiont
DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
University of Colorado
University of Colorado investment in Series B - Q32 Bio
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series B - Q32 Bio
Sanofi Ventures
Sanofi Ventures investment in Series B - Q32 Bio
Atlas Venture
Atlas Venture investment in Series B - Q32 Bio
Children’s Hospital Colorado
Children’s Hospital Colorado investment in Series B - Q32 Bio
Acorn Bioventures
Acorn Bioventures investment in Series B - Q32 Bio
Abingworth
Abingworth investment in Series B - Q32 Bio
OrbiMed
OrbiMed investment in Series B - Q32 Bio
Abingworth
Abingworth investment in Series A - Q32 Bio
Atlas Venture
Atlas Venture investment in Series A - Q32 Bio
Official Site Inspections
http://www.q32bio.com Semrush global rank: 1.28 M Semrush visits lastest month: 23.09 K
- Host name: 161.52.148.146.bc.googleusercontent.com
- IP address: 146.148.52.161
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Q32 Bio"
Our Team - Q32
Mary previously served as Special Advisor to the Bill & Melinda Gates Medical Research Institute, a non-profit biotech organization. Prior to that, Mary held various senior leadership positions at Dimension Therapeutics, Inc., a gene …See details»
Q32 Bio and Homology Medicines Announce Merger Agreement
Nov 16, 2023 Management and Organization. Upon closing of the proposed transaction, the …See details»
Q32 Bio - Crunchbase Company Profile & Funding
Contact Email [email protected] Q32 Bio is a biotechnology company developing treatments for patients with severe autoimmune and inflammatory diseases. …See details»
Q32 Bio Inc. - LinkedIn
To view our most recent press release and learn more, please visit www.q32bio.com. #ASN2024 #Q32Bio #QTTB. 47 Like Comment Share Q32 Bio Inc. 4,270 followers ...See details»
Q32 Bio Announces Closing of Merger with Homology Medicines …
Q32 Bio to focus on advancement of bempikibart (ADX-914) in ongoing atopic dermatitis (AD) …See details»
Q32 Bio Inc. (QTTB) Company Profile & Overview - Stock Analysis
3 days ago Q32 Bio Inc., a clinical-stage biotechnology company, develops biologic …See details»
Q32 Bio Company Profile - Office Locations, Competitors ... - Craft
Q32 Bio is a biotechnology company developing treatments for patients with severe …See details»
Release Details - ir.q32bio.com
For more information, please visit www.Q32bio.com. About Atlas Venture Atlas Venture is a …See details»
Release Details - Q32 Bio Inc.
Q32 Bio is currently conducting a first-in-human, Phase 1, ascending dose (SAD/MAD) clinical …See details»
Q32 Bio and Homology Medicines Announce Merger Agreement
Nov 16, 2023 Management and Organization. Upon closing of the proposed transaction, the …See details»
Q32 Bio, a Clinical Stage Biotechnology Company Focused on …
Sep 20, 2022 For more information, please visit www.Q32bio.com. Q32 Bio Contacts: …See details»
Q32 Bio, a Clinical Stage Biotechnology Company Focused on …
Sep 20, 2022 Q32 Bio is currently conducting a first-in-human, Phase 1, ascending dose …See details»
Q32 Bio Launches to Develop Novel Therapeutics Targeting …
May 27, 2020 Q32 Bio Launches to Develop Novel Therapeutics Targeting Regulators of …See details»
Q32 Bio Closes $60 Million Series B Financing, Advances to Clinical ...
Oct 29, 2020 For more information, please visit www.Q32bio.com. ### Media Contact Arleen …See details»
Q32 Bio Reports First Quarter 2024 Financial Results and Provides ...
May 9, 2024 Q32 Bio Inc. (NASDAQ: QTTB) ("Q32 Bio"), a clinical stage biotechnology …See details»
Our Approach - Q32
Bempikibart (ADX-914), Q32 Bio’s most advanced product candidate, is a fully human anti-IL-7 …See details»
Q32 Bio Closes $60 Million Series B Financing, Advances to Clinical ...
Oct 29, 2020 Q32 Bio Closes $60 Million Series B Financing, Advances to Clinical Stage …See details»
Our Pipeline - Q32
For pipeline inquiries, please contact: [email protected]. IL-7/TSLP Program Promising data …See details»